Partner Headlines - MDCO

  1. Regeneron/Sanofi PCSK9 Cholesterol Drug Wins FDA OK

    IBD
  2. Medicines Co. gets upgrade

    IBD
  3. Medicines Co., Eagle Pharma Up On Analyst Actions

    IBD
  4. The Medicines Company Announces FDA Approval of KENGREAL as an ...

    Benzinga
  5. Netflix Profit Above Consensus, Panera Bread Boosts Buyback Plan, ...

    GuruFocus
  6. FDA Advisory Committee Recommends Approval of The Medicines Company's ...

    Benzinga
  7. Blood clot preventer gets nod

    IBD
  8. Earnings Scheduled For February 18, 2015

    Benzinga
  9. Tetraphase Fights Drug-Resistant Bugs As M&A Heats Up

    IBD
  10. Catalysts To Watch For In RBC Capital's 2015 Top Small-Cap Biotechs

    Benzinga
  11. Benzinga's Top Upgrades

    Benzinga
  12. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  13. What Investors Should Expect From Rockwell Medical's Next FDA ...

    Benzinga
  14. Mid-Morning Market Update: Markets Surge; Monsanto Profit Tops ...

    Benzinga
  15. Morning Market Losers

    Benzinga
  16. Tuesday's After-Hours Movers

    Benzinga
  17. The Medicines Company Surges Amid Credit Suisse Upgrade

    Benzinga
  18. US Stock Futures Surge Ahead Of Earnings, ADP Data

    Benzinga
  19. The Medicines Company Announces First Patient Enrollment In Phase ...

    Benzinga
  20. Midday Gainers From October 28: Buffalo Wild Wings, Integrated ...

    Benzinga
  21. Morning Market Movers

    Benzinga
  22. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga
  23. BACTIVTM Phase 3 SOLO II Trial Results Published In The Journal ...

    Benzinga
  24. Actavis Expands Antibiotics Presence With Durata Buy

    IBD
  25. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  26. Benzinga's Top Downgrades

    Benzinga
  27. Benzinga's Top Downgrades

    Benzinga
  28. Medicines Co.

    IBD
  29. Mid-Afternoon Market Update: Compuware Holds Onto Gains, Clearwire ...

    Benzinga
  30. Stocks Higher In Afternoon; Thor Industires Jumps

    IBD
  31. Mid-Day Market Update: Verint Shares Jump On Upbeat Results; ...

    Benzinga
  32. Medicines Co. Down On Setback In Hospira Patent Case

    IBD
  33. Stocks Hitting 52-Week Lows

    Benzinga
  34. Mid-Morning Market Update: Markets Gain; Ford March Sales Rise ...

    Benzinga
  35. Morning Market Losers

    Benzinga
  36. Benzinga's Top #PreMarket Losers

    Benzinga
  37. Medicines Co. earnings miss

    IBD
  38. Earnings Scheduled For February 19, 2014

    Benzinga
  39. FDA nixes Medicines' drug

    IBD
  40. Mid-Afternoon Market Update: Market Rally Levels Out As Time ...

    Benzinga
  41. Mid-Day Market Update: U.S. Stocks Rise; Orbitz Shares Surge ...

    Benzinga
  42. Medicines Co. Downgraded After FDA Panel Rejects Drug

    IBD
  43. Mid-Morning Market Update: Markets Drop; Comcast To Acquire Time ...

    Benzinga
  44. Stocks Hitting 52-Week Lows

    Benzinga
  45. UPDATE: Credit Suisse Downgrades The Medicines Company Following ...

    Benzinga
  46. Benzinga's Top #PreMarket Losers

    Benzinga
  47. UPDATE: The Medicines Co. Reminds Investors of FDA CRDAC Meeting ...

    Benzinga
  48. Mid-Afternoon Market Update: Red Robin Continues to Rally as ...

    Benzinga
  49. Leaders Hold Near Buy Points Despite Monday Sell-Off

    IBD
  50. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD
  51. Scanning Leading Stocks For Earnings Growth In 2014

    IBD
  52. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  53. Medicines acquires Rempex

    IBD
  54. Benzinga's M&A Chatter for Wednesday December 4, 2013

    Benzinga
  55. Medicines Co. Acquires Rempex Pharma; Street Applauds

    IBD
  56. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga
  57. Five Medical Stocks Leaders Trade Near New Highs

    IBD
  58. A Few Stocks Form Bases, But Have Flaws

    IBD
  59. Strong Pipeline Expected To Drive Growth At Medicines Co.

    IBD
  60. Medicines Co. Mostly Steady After Low-Volume Breakout

    IBD
  61. ViroPharma Gets Bought Out; Medicines Clears Entry

    IBD
  62. Santarus Earnings Should Top 4 Hot Small-Cap Medicals

    IBD
  63. Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  64. LinkedIn, Alliance Fiber Lead Q3 Young Gun Earnings

    IBD
  65. Medicines Co. In Late Stages Of Base Formation

    IBD
  66. Medicines Co. sales topped

    IBD
  67. Medicines Co. Reports Mixed Q3 As New Products Await

    IBD
  68. Medicines Co. Sales Beat Estimates As Angiomax Grows

    IBD
  69. UPDATE: Leerink Swann Raises PT on The Medicines Company Following ...

    Benzinga
  70. The Medicines Company, Alnylam Announce Advance Development ...

    Benzinga
  71. The Medicines Company's Publishes Phase III Data from Trials ...

    Benzinga
  72. UPDATE: Bank of America Upgrades Medicines Company on Leverage

    Benzinga
  73. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
  74. The Medicines Company Announces Proposed Public Offering of 5.5 ...

    Benzinga
  75. The Medicines Company Announces Positive Phase III Trial Results ...

    Benzinga
  76. Questcor Leads Top 5 Small-Cap, Medical Stocks

    IBD
  77. The Medicines Co., Bristol-Myers Begin Alliance for Recothrom

    Benzinga
  78. Medicines Co. Holding On To Its Recent Big Gains

    IBD
  79. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 7,500 Shares

    GuruFocus
  80. Jefferies Reiterates Buy Rating, $34 PT on Partnership with Alnylam ...

    Benzinga
  81. A Peek Into The Market Before The Trading Starts

    Benzinga
  82. The Medicines Company, Alnylam Announce Global Alliance

    Benzinga
  83. Regeneron, Other Biomed Stocks Rebound On New Drugs

    IBD
  84. 3D Systems Leads Top 5 Small Caps Despite Stock Slide

    IBD
  85. Weekly CFO Sells Highlight: BK, MDCO, EBAY, MS, PHMD

    GuruFocus
  86. Weekly CFO Sells Highlight: MDCO, SIG, VCI, PHMD, SNPS

    GuruFocus
  87. Medicines (MDCO) President & CFO Glenn Sblendorio sells 125, ...

    GuruFocus
  88. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 2,500 Shares

    GuruFocus
  89. Small Cap Leaders: 3D Systems, IXIA Lead Top 5 Stocks

    IBD
  90. Celgene Leads 6 Medical Stocks With Bolting RS Lines

    IBD
  91. Medicines (MDCO) President & CFO Glenn Sblendorio sells 25,0 ...

    GuruFocus
  92. 5 Key Stock Moves From JPMorgan Health Care Confab

    IBD
  93. UPDATE: Bank of America Merrill Lynch Reiterates Neutral Rating, ...

    Benzinga
  94. Eylea Sales Hurt Regeneron

    IBD
  95. Mid-Afternoon Market Update: Markets Fall Further, Isis Pharma ...

    Benzinga
  96. Medtech Stocks Moving As Conference Makes Waves

    IBD
  97. Medtech Stocks Moving As Conference Makes Waves

    IBD
  98. Mid-Day Market Update: Markets Remain Down, The Medicines Company ...

    Benzinga
  99. The Medicines Co. Offers Results of Phase 3 Trial of Cangrelor ...

    Benzinga
  100. Medicines (MDCO) Chairman & CEO Clive Meanwell sells 5,000 Shares

    GuruFocus
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!